The present study was designed to determine if the dose of purified ovulation-inducing factor (OIF) from llama seminal plasma required to provoke an ovulatory response is physiologically relevant in terms of the proportion present in a normal ejaculate and to test the hypothesis that corpus luteum (CL) form and function are affected by OIF in a dose-dependent manner. Female llamas were assigned randomly to five groups (n ¼ 10 per group) and given a single i.m. dose of 500, 250, 125, or 60 lg of purified OIF (representative of the amount present in 1/25th to 1/200th of a normal ejaculate) or 1 ml of PBS (control). Ovulation and CL development were monitored by transrectal ultrasonography. Blood samples were taken to measure plasma progesterone concentrations and to determine changes in plasma concentrations of luteinizing hormone (LH). The high dose of OIF (500 lg) was associated with the highest incidence of ovulation (P , 0.05), the greatest maximum CL diameter (P , 0.05), and the largest day-to-day profiles of CL diameter (P , 0.05) and plasma progesterone concentrations (P , 0.01). A rise in plasma LH concentration was apparent in all llamas that ovulated and was most rapid and highest in the high-dose group (P , 0.01). The low dose of OIF (60 lg) was minimally effective for induction of ovulation and the least luteotrophic, as evidenced by the smallest maximum CL diameter and the smallest day-to-day profiles for CL diameter and plasma concentrations of progesterone and LH. Responses were intermediate for the middle-dose groups (125 and 250 lg). We conclude that OIF from llama seminal plasma has a dosedependent effect on ovulation rate and CL form and function in llamas and that the biological effect of OIF is evident at physiologically relevant doses (i.e., as little as 1/100th of that present in an ejaculate).
INTRODUCTION
Ovulation is a process preceded by an elevation in circulating plasma luteinizing hormone (LH) concentrations [1] that culminates with the rupture and evacuation of the contents of the dominant follicle [2] . Mammalian species have been classified as either induced ovulators or spontaneous ovulators [3] . In spontaneous ovulators, the preovulatory LH surge is triggered by a positive-feedback effect of rising circulating concentrations of estradiol, secreted mainly by the dominant follicle, in the absence of progesterone [1, 4] . In contrast, the trigger for eliciting the preovulatory LH surge in induced ovulators, such as camelids, has been attributed primarily to a neuroendocrine response to the physical stimulation of the genitalia during copulation or other physical stimulation, such as olfactory, auditory, or visual factors [5] [6] [7] . However, the authors of an early study on Bactrian camels, also considered induced ovulators, suggested the presence of an ovulation-inducing factor (OIF) in the semen of this species [8] . More recently, the presence of an OIF in the seminal plasma of llamas and alpacas was convincingly documented by the observation that ovulation occurred in more than 90% of females treated intramuscularly with seminal plasma [9, 10] . Ovulation in seminal plasma-treated animals was consistently preceded by a rise in plasma LH concentrations. The magnitude of the LH response was greater in seminal plasma-treated animals than in gonadotropin-releasing hormone (GnRH)-treated animals [9] and was associated with an increase in corpus luteum (CL) diameter and plasma progesterone concentration, suggesting a powerful luteotrophic effect. Results of a study comparing routes of administration were consistent with a systemic rather than a local mode of action for OIF [10] . More females ovulated after i.m. treatment than after intrauterine deposition of seminal plasma (93% vs. 41%), and the ovulation rate was intermediate (67%) for animals treated by intrauterine deposition followed by endometrial curettage [10] . This finding is also consistent with the results of a study in which alpaca seminal plasma stimulated secretion of LH from rat pituitary cells in vitro [11] .
The biologically active fraction of llama and alpaca seminal plasma was identified recently as a robust protein that is resistant to enzymatic digestion with proteinase K and incubation at 388C for 12 h or 658C for 1 h. Only enzymatic digestion with pronase E abolished the ovulation-inducing activity of llama seminal plasma [12] . Using a two-step combination of hydroxylapatite and gel filtration chromatography, OIF was isolated from llama seminal plasma as a 14-kDa protein molecule [13] . Previous studies of OIF [8] [9] [10] [11] [14] [15] [16] [17] have involved treatment with whole seminal plasma; however, purified OIF was used in the present study.
The present study aimed to determine if the minimum dose of purified OIF required to provoke an ovulatory response is physiologically relevant in terms of the proportion present in a normal ejaculate. The present study also tested the hypothesis that CL form and function are affected by OIF in a dosedependent manner.
MATERIALS AND METHODS

Seminal Plasma Collection
Semen was collected from four mature male llamas (age, 5-7 yr) two or three times a week over a period of 2 mo using an artificial vagina inserted into a wooden phantom [18] . A total of 72 ejaculates were obtained (n ¼ 18 per male). Semen samples were processed as previously described [9] . Briefly, ejaculates were diluted 1:1 (v/v) with PBS (pH 7.4; Invitrogen), drawn backand-forth through an 18-guage needle attached to a 10-ml syringe, and centrifuged at 1500 3 g for 30 min to separate plasma from spermatozoa. A drop of the supernatant was then evaluated by microscopy to confirm the absence of cells. If spermatozoa were detected, the sample was centrifuged and evaluated again as described above until no spermatozoa were detected. The average ejaculatory volume was 2 ml; therefore, the diluted volume per sample was, on average, 4 ml. Diluted, sperm-free samples were stored at À708C until further purification.
Protein Purification
Upon thawing, seminal plasma samples were pooled and purified in 12 elution replicates, each with approximately 12 ml of seminal plasma, as previously described [13] . In brief, after sonication and centrifugation, the seminal plasma was loaded onto a type 1 macroprep ceramic hydroxylapatite column (20 lm; Bio-Rad Laboratories) that was previously equilibrated with 10 mM sodium phosphate (pH 6.8). Approximately 24-30 mg of total protein were loaded onto the column (1 3 10 cm) for each replicate, and elution was done at room temperature with a flow rate of 0.5 ml/min using a linear gradient with 350 mM sodium phosphate (pH 6.8). Fractions were collected, and their absorbance was measured at 280 nm. Fraction C [13] was concentrated and buffer exchanged in PBS (pH 7.4) using a 20-ml ultrafilter device with a membrane cutoff of 5 kDa (Vivaspin; Vivascience/Sartorius). Further purification was done by loading fraction C (;6-8 mg/replicate) onto a 320-ml size-exclusion column (Hi Prep 26/60 Sepahacryl S-100; GE Health Sciences) attached to an AKTA fast protein liquid chromatography system (Amersham Biosciences, Inc.). Samples were eluted isocratically using PBS (pH 7.4) at a flow rate of 0.5 ml/min, and elution volumes corresponding to fraction C 2 (purified OIF [13] ) were concentrated as described above. Samples of fraction C 2 were stored at À708C and, upon thawing, were diluted with PBS to prepare doses of 500, 250, 125, and 60 lg/ml of total protein (purified OIF). Protein concentration was determined using the microassay method (Protein Assay; Bio-Rad) based on the method first described by Bradford [19] .
Animals and Treatments
Mature, nonlactating female llamas (n ¼ 10 llamas/group; age, !4 yr; weight, 90-120 kg) were selected from a herd of 53 llamas during July and August at the University of Saskatchewan, Canada (528N, 1068W; 500 m above sea level). Llamas were examined daily by transrectal ultrasonography using a 7.5-MHz linear-array transducer (Aloka SSD900) [20] , and when a growing follicle (diameter increase for three consecutive days) of 7 mm or greater was detected [21] , they were assigned randomly to one of four treatment groups (n ¼ 10 llamas/group). Llamas were given a single i.m. injection (semimembranosus or semitendinosus muscle) of 1 ml PBS (negative control) or 500, 250, or 125 lg of purified OIF in 1 ml of PBS. Doses were based on the results of previous studies in which a relatively conservative i.m. dose of 1-2 ml of diluted (1:1, v/ v), unpurified seminal plasma (i.e., one quarter to one half of an ejaculate based on an average volume of 2 ml/ejaculate [18] ) resulted in 90%-100% ovulation in female llamas [9, 10] . The mean total protein in llama seminal plasma was 12.4 mg/ml, and OIF constituted approximately 50% of total protein [13] . Hence, the doses used in previous studies are equivalent to 3-6 mg of OIF. The doses in the present study, therefore, represent 1/100th (125 lg), 1/50th (250 lg), and 1/25th (500 lg) of the amount of OIF normally present in a single ejaculate.
The experiment was conducted in two replicates (first replicate, n ¼ 6 per group; second replicate, n ¼ 4 per group). The second replicate involved frequent blood sampling to determine the endogenous LH response to treatment. To facilitate data collection in the second replicate, follicular wave emergence was synchronized among animals by giving a single i.m. dose of porcine luteinizing hormone (pLH; 5 mg Armour standard; Lutropin-V; Bioniche Animal Health) [14] to all animals on the same day. Llamas were reexamined 12 days later-enough time to allow CL regression in those that ovulated in response to pLH treatment and for all to have developed a new mature dominant follicle. Llamas with a follicle 7 mm or larger and no CL were assigned randomly to the respective treatment groups. Based on the unexpectedly high ovulatory response to all doses of OIF in the first replicate, an additional group was included in the second replicate (n ¼
daily by transrectal ultrasonography until Day 4 (Day 0 ¼ day of treatment) to detect ovulation and every other day thereafter until Day 16 to monitor CL form and function [22] . Ovulation was defined as the disappearance of a large follicle (!8 mm) from one examination to the next and was confirmed by the detection of a CL in subsequent examinations [20] . The onset of CL regression was defined as the first day the CL began a progressive decrease in diameter [9] .
For measurement of plasma progesterone concentration in both replicates, blood samples were collected from the jugular vein into heparinized tubes (Vacutainer Systems; Becton Dickinson) every other day starting from the day of treatment. Plasma progesterone concentration was measured using a commercially available double-antibody radioimmunoassay kit (Coat-A-Count Total Progesterone; Diagnostic Products Corporation) [22] . Samples were analyzed in two consecutive assays with intra-assay coefficients of variation of 4.5%, 3.2%, and 8.8% for reference concentrations of 1.9, 3.6, and 16.6 ng/ml, respectively, for the first assay and of 6.8%, 2.0%, and 1.7% for reference concentrations of 1.6, 3.2, and 16.0 ng/ml, respectively, for the second assay. Interassay coefficients of variations were 9.2%, 6.5%, and 6.9% for reference concentrations of 1.78, 3.49, and 16.36 ng/ml, respectively.
More frequent blood samples were collected from four animals per group in the second replicate for measurement of plasma LH concentration [9] . Samples were taken immediately before treatment (Hour 0), every 15 min until Hour 2, and again at Hours 3, 4, 5, 6, 7, 8, and 12. A catheter was placed in the jugular vein on the day before treatment to minimize the effect of stress at the time of sampling. All samples were centrifuged within 2 h of collection at 1700 3 g for 20 min, and plasma was stored at À208C. Plasma LH concentrations were measured using a double-antibody radioimmunoassay [9] and are expressed in terms of NIAMDDK-oLH-24. The minimum detectable limit of the assay was 0.1 ng. The range of the standard curve was 0.06 ng (80% ligand-labeled LH) to 8.0 ng (20% ligand-labeled LH). The intra-and interassay coefficients of variation for the low reference plasma LH concentration (0.13 ng/ml) were 10.3% and 8.3%, respectively. The intra-and interassay coefficients of variation for the high reference plasma LH concentration (0.99 ng/ml) were 11.1% and 10.0%, respectively.
The experimental protocol was approved by the University of Saskatchewan Committee on Animal Care and Supply in accordance with the guidelines of the Canadian Council on Animal Care.
Statistical Analyses
Single-point measurements (i.e., follicle size at the time of treatment, day of appearance of the CL, maximum CL diameter, and CL diameter on Days 8 and 14) were compared by two-way ANOVA to determine the effects of treatment and replicate. Serial data (i.e., plasma progesterone and LH concentrations and CL diameter profile) were compared among groups by two-way ANOVA for repeated measures to determine the effects of treatment, replicate, and their interaction with time (SAS software; SAS Institute, Inc.). In the absence of a replicate effect, data from the two replicates were combined. Tukey multiple comparison was used as a post-hoc test when a main effect of treatment or a treatment interaction was detected. Ovulation rates were compared among groups by chi-square analysis. Significance was assumed when the probability of values differing by chance alone was 0.05 or less. Data were centralized to the day of treatment (Day 0) for preparation of figures.
RESULTS
The diameter of the preovulatory follicle at the time of treatment did not differ among groups (P ¼ 0.3) ( Table 1 ). The proportion of llamas that ovulated was lower (P , 0.05) in the control and low-dose (60-lg) groups compared to the higherdose groups (Table 1) . 
DOSE-DEPENDENT EFFECT OF OVULATION-INDUCING FACTOR
In those llamas that ovulated, the CL was detected earliest (P , 0.05) and reached the greatest diameter (P , 0.05) in the high-dose (500-lg) group (Table 2) . Conversely, CL detection was latest (P , 0.05) and diameter was smallest (P , 0.05) in the low-dose (60-lg) group. By Day 14 after treatment, the diameter of the regressing CL did not differ among groups (Table 2 ). The day-to-day CL diameter profile was greatest in the 500-lg group, intermediate for the 250-and 125-lg groups, and lowest for the 60-lg group (day effect, P , 0.01; group effect, P , 0.05; day 3 group interaction, P , 0.01) (Fig. 1) .
Plasma progesterone concentrations in those llamas that ovulated were highest in the high-dose group (day effect, P , 0.01; group effect, P ¼ 0.03; day 3 group interaction, P ¼ 0.15) (Fig. 1) . This effect was more evident when all animals, regardless of whether they ovulated, were taken into consideration (day effect, P , 0.01; group effect, P , 0.01; day 3 group interaction, P , 0.01) (Fig. 1) .
A rise in plasma LH concentration was apparent in all llamas that ovulated and was absent in all that failed to ovulate. Data from all animals were included in the analysis of the dayto-day LH profile (Fig. 2 ) except for one llama from each of the 60-, 250-, and 500-lg groups in which plasma concentrations of LH, averaged over all days, was more than 14 SD above the average for the group (outliers). Despite the high LH values, ovulation was not detected in these individuals. Over the 12-h sampling period, a time 3 group interaction in plasma LH concentrations (P , 0.01) was the result of a more rapid increase in progressively higher-dose groups and a greater and more sustained elevation in the high-dose group than in all other groups. The magnitude of the LH profile decreased in a dose-related manner.
DISCUSSION
Ovulation-inducing factor is a proteinase K-resistant, pronase-sensitive protein constituent of the seminal plasma of llamas and alpacas [12] responsible for eliciting ovulation in these species [9] . Using a combination of hydroxylapatite and gel-filtration chromatography, purified OIF was isolated as a protein with a molecular mass of 14 kDa [13] but with bioactive forms at both 14 kDa and approximately 30 kDa [13] . The purified protein elicited a preovulatory LH surge followed by ovulation and CL formation in llamas after i.m. administration [13] . Compared to animals treated with GnRH, the OIFinduced preovulatory surge of LH lasted longer, and subsequent CL development was larger and plasma progesterone concentrations twice as high [9] .
Results of the present study support the hypothesis that OIF exerts a dose-dependent effect on ovulation and CL form and function. Four different doses were chosen based on the estimate that an average ejaculate of 2 ml [18] contains approximately 3-6 mg of OIF [13] . Thus, the maximum dose in this experiment (500 lg) represents 1/25th of what is normally present in an ejaculate, and because an intermediate dose (125 lg) still induced ovulations in 70% of the females in the first replicate of the present study, a low dose representative of approximately 1/200th of the normal amount present in a single ejaculate was added in the second replicate. The dose effect was manifest by higher ovulation rates (90% in the highdose group, P , 0.05), earlier appearance of the CL, a larger &) or PBS ( * ; n ¼ 11 per group). In c, data from llamas that did not ovulate were excluded (i.e., n ¼ 3, 7, 9, and 9 in groups treated with 60, 125, 250, or 500 lg, respectively, of OIF). Data are presented as the mean 6 SEM.
454 maximum CL diameter, and greater CL diameter profiles in the high-dose group. Conversely, ovulation rates and CL characteristics were lowest in the low-dose group and intermediate for the 125-and 250-lg groups. As in previous studies [9, 13] , OIF-induced ovulation was preceded by an elevation in plasma LH concentrations. Plasma LH concentrations were highest in the high-dose group and lowest in the low-dose and salinetreated groups. Plasma progesterone concentrations were also highest in the high-dose group, supporting the hypothesis of a luteotrophic effect of OIF. A dose-related effect on plasma progesterone concentrations was evident even among only those that ovulated in each group; however, the lack of statistical difference between the highest-and lowest-dose groups was attributed to the low number of animals that ovulated in the latter (n ¼ 3). Differences in doses are consistent with earlier observations that 1 ml of seminal plasma deposited into the uterine body of alpacas did not result in ovulations [9] , whereas 1 ml of seminal plasma deposited into each uterine horn (2 ml total) resulted in a 41% ovulation rate in a subsequent experiment [10] .
Intramuscular rather than intrauterine treatment was chosen in the present experiment to minimize the potential confounding effects of local stimulation of the genitalia. In addition, previous results [10] documented a significantly higher incidence of ovulation following i.m. administration of seminal plasma compared to intrauterine deposition in female alpacas (93% vs. 41%). The effect of OIF was mediated via a systemic (indirect) rather than a local (direct) route, as evidenced by the observations that treatment with OIF was followed by a surge in circulating concentrations of LH and that the incidence of ovulation increased from 41% to 67% when intrauterine deposition was followed by endometrial curettage [10] . This was consistent with the findings in the same species in which a dose of LH (5 mg; Lutropin) induced ovulation in more than 80% of alpacas when given i.m. [15, 23] but failed to induce ovulation when given by intrauterine deposition [9] . Similarly, in rabbits, the dose of a GnRH analogue required to induce ovulation was 10-fold higher when infused into the uterus than when given i.m. (8 vs. 0.8 lg of buserelin per female) [24] .
In summary, OIF is a potent ovulation-inducing protein found at high concentrations in the seminal plasma of llamas. A dose-dependent effect of OIF was demonstrated by 1) greater incidence of ovulation, 2) larger CL diameters, and 3) higher plasma progesterone concentrations in animals treated with a higher dose (500 lg) of purified OIF compared with lower doses. Results document that OIF exerts its effects at physiologically relevant doses; the minimum effective dose used in the present study was 125 lg of purified OIF, equivalent to that present in approximately 1/100th of a normal ejaculate.
